恩华药业(002262.SZ)：盐酸他喷他多片获药品注册证书

Group 1 - The core point of the article is that Enhua Pharmaceutical has received approval from the National Medical Products Administration for the registration of its chemical drug, Tazobactam Hydrochloride Tablets [1] Group 2 - The Tazobactam Hydrochloride Tablets are intended for the treatment of acute pain in adult patients who require opioid medications, as well as for acute pain that is not adequately relieved by alternative treatments [1]